Skip to main content

Table 2 Logistic regression analysis of survial time after double stenting

From: Efficacy and safety of chemotherapy after endoscopic double stenting for malignant duodenal and biliary obstructions in patients with advanced pancreatic cancer: a single-institution retrospective analysis

 

Univariable analysis

Multivariable analysis

Variable

OR (95% CI)

P value

OR (95% CI)

P value

Age (≥65)

0.79 (0.43–1.42)

0.43

  

Gender (M)

0.77 (0.40–1.53)

0.45

  

Distant metastaisis at initial diagnosis (yes)

1.26 (0.69–2.42)

0.46

  

Timing of double stenting (Simultaneous)

0.64 (0.34–1.17)

0.15

  

Type of stent (PS)

0.43 (0.19–0.87)

0.018

0.82 (0.29–2.05)

0.68

Biliary drainage method (EUS-BD)

0.29 (0.13–0.57)

0.0002

0.45 (0.16–1.13)

0.093

Reintervention for DU stent dysfunction (yes)

0.24 (0.078–0.59)

0.0012

0.42 (0.098–1.54)

0.19

Reintervention for BS dysfunction (yes)

0.33 (0.15–0.68)

0.0018

0.21 (0.081–0.50)

0.0002

Chemotherapy post double stenting (yes)

0.14 (0.067–0.30)

<.0001

0.19 (0.059–0.60)

0.0051

Performance status (< 2)

0.11 (0.048–0.23)

<.0001

0.28 (0.098–0.71)

0.0064

  1. OR odds ratio, CI confidence interval, PS plastic stent, EUS-BD endoscopic ultrasound-guided biliary drainage, DU duodenal stent, BS biliary stent